Baclofen and Hepatic steatosis - a phase IV clinical study of FDA data
Hepatic steatosis is found among people who take Baclofen, especially for people who are female, 40-49 old, have been taking the drug for 1 - 2 years.
The phase IV clinical study analyzes which people take Baclofen and have Hepatic steatosis. It is created by eHealthMe based on reports of 92,574 people who have side effects when taking Baclofen from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
92,574 people reported to have side effects when taking Baclofen.
Among them, 303 people (0.33%) have Hepatic steatosis.
What is Baclofen?
Baclofen has active ingredients of baclofen. It is often used in muscle spasms. eHealthMe is studying from 94,975 Baclofen users for its effectiveness, alternative drugs and more.
What is Hepatic steatosis?
Hepatic steatosis (fatty liver disease) is found to be associated with 1,992 drugs and 1,328 conditions by eHealthMe.
Number of Baclofen and Hepatic steatosis reports submitted per year:
Time on Baclofen when people have Hepatic steatosis *:
Gender of people who have Hepatic steatosis when taking Baclofen*:
Age of people who have Hepatic steatosis when taking Baclofen *:
Common drugs people take besides Baclofen *:
Common side effects people have besides Hepatic steatosis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Baclofen and have Hepatic steatosis?Check whether Hepatic steatosis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Hepatic steatosis and when was it recovered:
Expand to all the drugs that have ingredients of baclofen:
- Hepatic steatosis and drugs with ingredients of baclofen (320 reports)
Alternative drugs to, pros and cons of Baclofen:
- Baclofen (94,975 reports)
Common Baclofen side effects:
- Fatigue (feeling of tiredness): 8,035 reports
- Pain: 7,405 reports
- Weakness: 6,862 reports
- Drug ineffective: 5,722 reports
- Headache (pain in head): 5,381 reports
Browse all side effects of Baclofen:a b c d e f g h i j k l m n o p q r s t u v w x y z
Hepatic steatosis treatments and more:
- Hepatic steatosis (22,021 reports)
COVID vaccines that are related to Hepatic steatosis:
- Hepatic steatosis in Moderna COVID Vaccine
- Hepatic steatosis in Pfizer BioNTech Covid Vaccine
- Hepatic steatosis in Johnson and Johnson Covid Vaccine
Common drugs associated with Hepatic steatosis:
- Methotrexate: 2,108 reports
- Prednisone: 1,489 reports
- Metformin: 1,468 reports
- Humira: 1,407 reports
- Aspirin: 1,225 reports
- Enbrel: 1,014 reports
- Lipitor: 883 reports
- Omeprazole: 849 reports
- Zometa: 840 reports
- Pantoprazole: 828 reports
All the drugs that are associated with Hepatic steatosis:
- Hepatic steatosis (1,992 drugs)
Common conditions associated with Hepatic steatosis:
- Rheumatoid arthritis: 2,047 reports
- High blood pressure: 1,957 reports
- Depression: 943 reports
- Multiple sclerosis: 929 reports
- Pain: 899 reports
- High blood cholesterol: 860 reports
- Psoriasis: 794 reports
- Type 2 diabetes: 772 reports
All the conditions that are associated with Hepatic steatosis:
- Hepatic steatosis (1,328 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on baclofen (the active ingredients of Baclofen) and Baclofen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hydralazine Hydrochloride vs. Timolol Maleate - now
- Constipation and Lactose Intolerance - 3 seconds ago
- Kaletra vs. Didanosine - 7 seconds ago
- Pot vs. Risperdal - 7 seconds ago
- Nph Insulin vs. Glucovance - 17 seconds ago
- Vicoprofen vs. Dexamethasone - 19 seconds ago
- Syeda vs. Estradiol - 20 seconds ago
- Excedrin vs. Zomig-Zmt - 29 seconds ago
- Solu-Medrol and Rebif drug interaction - 38 seconds ago
- Paclitaxel and Lyrica drug interaction - 46 seconds ago